Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $14.00 and last traded at $14.05, with a volume of 656358 shares trading hands. The stock had previously closed at $16.05.
Analyst Ratings Changes
ARDT has been the topic of several recent research reports. Truist Financial lowered their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Stephens reiterated an "overweight" rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. Finally, KeyCorp assumed coverage on Ardent Health Partners in a report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target for the company. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $22.00.
Read Our Latest Stock Report on ARDT
Ardent Health Partners Stock Performance
The company has a 50-day moving average price of $16.45. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.
Institutional Investors Weigh In On Ardent Health Partners
Institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets purchased a new position in Ardent Health Partners during the third quarter valued at $42,000. Financial Management Professionals Inc. bought a new position in shares of Ardent Health Partners during the 3rd quarter valued at about $50,000. MetLife Investment Management LLC purchased a new position in shares of Ardent Health Partners during the third quarter valued at about $135,000. JPMorgan Chase & Co. bought a new stake in shares of Ardent Health Partners in the third quarter worth about $154,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Ardent Health Partners in the third quarter worth about $229,000.
Ardent Health Partners Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
